The University of Kentucky Markey Cancer Center is one of 22 cancer centers nationwide to receive funding to build and implement tobacco cessation treatment programs via the National Cancer Institute’s Cancer Center Cessation Initiative (CCCI).
In 2017, NCI launched the Cancer Center Cessation Initiative as part of the NCI Cancer Moonshot℠ program. Through this initiative, Markey will receive $253,000 over the next year to help enhance the delivery of tobacco cessation treatments through four major efforts:
- Refining electronic medical records and clinical workflows to ensure the systematic identification and documentation of smokers and the routine delivery of evidence-based tobacco cessation treatment services
- Overcoming patient, clinician, clinic, and health system barriers to providing tobacco cessation treatment services
- Achieving institutional buy-in that treating tobacco use is a component of organizational “Standard of Care”
- Creating mechanisms to sustain tobacco cessation treatment services so that they continue beyond the funding period of the initiative
Kentucky has more cases of lung cancer than any other state, and its mortality rate is 50 percent higher than the national average.
Read full story at UK Now.